Search research articles
Contact Us
Filters
Showing results (11-20 of 229) with videos related to
Page
of 23
Sort By:
Seminars in Oncology
|
August 27, 2003
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
Rebecca J Bruner, Sherif S Farag
Advances in Pharmacology (San Diego, Calif.)
|
October 7, 2004
Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma
Sherif S Farag, Michael A Caligiuri
Stem Cells and Cloning : Advances and Applications
|
November 8, 2013
Increased mobilization and yield of stem cells using plerixafor in combination with granulocyte-colony stimulating factor for the treatment of non-Hodgkin's lymphoma and multiple myeloma
Louis M Pelus, Sherif S Farag
Indiana Medicine : the Journal of the Indiana State Medical Association
|
October 1, 1987
An evaluation of sucralfate in the treatment of peptic ulcer disease. A 'clinical real life study' of 54 patients in Indiana
W D Province, R S Farag
Advances in Neurology
|
May 23, 2003
Amyloidosis of cerebral arteries
Harry V Vinters, Emad S Farag
Blood Reviews
|
December 21, 2005
Human natural killer cell development and biology
Sherif S Farag, Michael A Caligiuri
The New England Journal of Medicine
|
September 16, 1982
Yersinia arthritis and Guillain-Barré syndrome
S S Farag, D B Gelles
Veterinary Medicine International
|
April 3, 2014
Clinical, Hematologic, and Molecular Findings in Naturally Occurring Babesia canis vogeli in Egyptian Dogs
N Y Salem, H S Farag
Seminars in Hematology
|
April 18, 2006
Immunologic approaches to acute leukemia in the elderly
Sherif S Farag, Michael A Caligiuri
Expert Opinion on Investigational Drugs
|
December 16, 2014
The potential role of PD0332991 (Palbociclib) in the treatment of multiple myeloma
Jeffrey D Altenburg, Sherif S Farag
Page
of 23
Search research articles
Search
Showing results (11-20 of 229) with videos related to
Sort By:
Page
of 23
Seminars in Oncology
|
August 27, 2003
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
Rebecca J Bruner, Sherif S Farag
Advances in Pharmacology (San Diego, Calif.)
|
October 7, 2004
Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma
Sherif S Farag, Michael A Caligiuri
Stem Cells and Cloning : Advances and Applications
|
November 8, 2013
Increased mobilization and yield of stem cells using plerixafor in combination with granulocyte-colony stimulating factor for the treatment of non-Hodgkin's lymphoma and multiple myeloma
Louis M Pelus, Sherif S Farag
Indiana Medicine : the Journal of the Indiana State Medical Association
|
October 1, 1987
An evaluation of sucralfate in the treatment of peptic ulcer disease. A 'clinical real life study' of 54 patients in Indiana
W D Province, R S Farag
Advances in Neurology
|
May 23, 2003
Amyloidosis of cerebral arteries
Harry V Vinters, Emad S Farag
Blood Reviews
|
December 21, 2005
Human natural killer cell development and biology
Sherif S Farag, Michael A Caligiuri
The New England Journal of Medicine
|
September 16, 1982
Yersinia arthritis and Guillain-Barré syndrome
S S Farag, D B Gelles
Veterinary Medicine International
|
April 3, 2014
Clinical, Hematologic, and Molecular Findings in Naturally Occurring Babesia canis vogeli in Egyptian Dogs
N Y Salem, H S Farag
Seminars in Hematology
|
April 18, 2006
Immunologic approaches to acute leukemia in the elderly
Sherif S Farag, Michael A Caligiuri
Expert Opinion on Investigational Drugs
|
December 16, 2014
The potential role of PD0332991 (Palbociclib) in the treatment of multiple myeloma
Jeffrey D Altenburg, Sherif S Farag
Page
of 23